Abstract

ObjectiveEstimate the prevalence of psychotropic drugs use in the city of Rio de Janeiro, Brazil, and establish its relationship with the presence of mental disorders.MethodsA probabilistic sample of non-institutionalized individuals, from the general population of Rio de Janeiro (n = 1208;turn out:81%), 15 years or older, who were interviewed using the Composite International Diagnostic Interview 2.1 (depression, anxiety-phobia, OCD\\PTSD, alcoholism sections), and asked about their psychotropic use during a 12 and one-month period before the interview. Data were collected between June/2007-February/2008.The prevalence was estimated with a confidence interval of 95%. The associations between psychotropics use and mental disorders were analyzed through a logistic regression model (Odds Ration – OR).ResultsThe one-month prevalence of psychotropic drug use was 6.55%, 3.19% for men and 9.13% for women. Antidepressants were the most frequently used drug (2.78%), followed by anorectics (1.65%), tranquilizers (1.61%) and mood stabilizers (1.23%). General practitioners issued the highest number of prescriptions (46.3%), followed by psychiatrists (29.3%); 86.6% of the psychotropic drugs used were paid for by the patient himself. Individuals with increased likelihood of using psychotropic drugs were those that had received a psychiatric diagnosis during a one-month period before the study (OR:3.93), females (OR:1.82), separated/divorced (OR:2.23), of increased age (OR:1.03), with higher income (OR:2.96), and family history of mental disorder (OR:2.59); only 16% of the individuals with a current DSM IV diagnosis were using a psychotropic drug; 17% among individuals with a depression-related diagnosis and 8% with Phobic Anxiety Disorders-related diagnosis used psychotropics.ConclusionApproximately 84% of individuals displaying some mental disorder did not use psychotropic drugs, which indicates an important gap between demand and access to treatment. A significant failure is evident in the health system for patients with mental disorders; this could be due to health workers' inability to recognize mental disorders among individuals.

Highlights

  • The prevalence of psychotropic drug use in the general population varies greatly between countries: 3.5% in England [[1], 6.4% in Chile [2], 7.2% in Canada [3], and 10.6% in Australia [4]

  • The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript

  • We focused on psychotropic use and psychiatric diagnosis one month before the study

Read more

Summary

Introduction

The prevalence of psychotropic drug use in the general population varies greatly between countries: 3.5% in England [[1], 6.4% in Chile [2], 7.2% in Canada [3], and 10.6% in Australia [4]. The European Study of the Epidemiology of Mental Disorders/Mental Health Disability: a European Assessment (ESEMed/MHEDEA 2000) [5], performed in six European countries (Belgium, France, Germany, Italy, the Netherlands and Spain), estimated an annual prevalence of 12.3%. The Medical Expenditure Panel Survey (MEPS) in the US reported annual prevalences of 5.9% in 1996, 7% in 2000, and 8.1% in 2001 [6]. An epidemiological study carried out in Rio de Janeiro by Almeida et al [9] in 1988 in the Governador Island county, estimated a prevalence of 5.2% in psychotropic use. At the beginning of the 90s, Mari et al reported a 12-month prevalence of 10.2% for 4 districts in the city of Sao Paulo [10], and in 1994 Lima et al [11] found an 12-month prevalence of 9.9% in the South of Brazil, among a population of 328,000 inhabitants

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.